OTSUKA AMERICA PHARMACEUTICAL, INC.
Pharmaceutical manufacturer.
The register keeps a separate record of this client for every firm that files for it and every spelling of its name. All 11 of its records are shown together here.
These two are not added together. An organisation lobbying for itself reports its own spending, and the firms it retains report what they were paid; the rules ask the first to include the second, but filings do not always do so and a filing gives no way to tell. Each is shown as reported.
Reported lobbying by year
Filings
| Filing | Filed by | Amount |
|---|---|---|
|
3rd Quarter - Report 3rd Quarter 2026
|
TODD STRATEGY GROUP | $50,000 reported |
|
3rd Quarter - Report 3rd Quarter 2026
|
DB3, LLC (FKA THE DASCHLE GROUP) | $30,000 reported |
|
3rd Quarter - Report 3rd Quarter 2026
|
W STRATEGIES, LLC | $50,000 reported |
|
3rd Quarter - Report 3rd Quarter 2026
|
THORN RUN PARTNERS | $50,000 reported |
|
3rd Quarter - Report 3rd Quarter 2026
|
OTSUKA AMERICA PHARMACEUTICAL, INC. | $310,000 reported |
|
2nd Quarter - Report 2nd Quarter 2026
|
TODD STRATEGY GROUP | $50,000 reported |
|
2nd Quarter - Report 2nd Quarter 2026
|
W STRATEGIES, LLC | $50,000 reported |
|
2nd Quarter - Report 2nd Quarter 2026
|
THORN RUN PARTNERS | $50,000 reported |
|
2nd Quarter - Report 2nd Quarter 2026
|
DB3, LLC (FKA THE DASCHLE GROUP) | $30,000 reported |
|
2nd Quarter - Report 2nd Quarter 2026
|
OTSUKA AMERICA PHARMACEUTICAL, INC. | $1,240,000 reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| OTSUKA AMERICA PHARMACEUTICAL, INC. In-house | 48 | $16,800,000 |
| TARPLIN, DOWNS & YOUNG, LLC | 16 | $1,200,000 |
| TODD STRATEGY GROUP | 20 | $1,000,000 |
| THORN RUN PARTNERS | 17 | $710,000 |
| W STRATEGIES, LLC | 16 | $700,000 |
| FEDERAL STREET STRATEGIES, LLC | 9 | $420,000 |
| DB3, LLC (FKA THE DASCHLE GROUP) | 9 | $370,000 |
| GOVERNMENT SOLUTIONS LLC | 9 | $270,000 |
| SQUIRE PATTON BOGGS | 3 | $270,000 |
| AKIN GUMP STRAUSS HAUER & FELD | 3 | $150,000 |
| BLUEBIRD STRATEGIES | 3 | $40,000 |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Health Issues | HCR | 140 |
| Medicare/Medicaid | MMM | 94 |
| Pharmacy | PHA | 35 |
| Budget/Appropriations | BUD | 25 |
| Taxation/Internal Revenue Code | TAX | 22 |
| Veterans | VET | 17 |
| Defense | DEF | 8 |
| Government Issues | GOV | 8 |
| Science/Technology | SCI | 6 |
| Medical/Disease Research/Clinical Labs | MED | 6 |
| Tariff (miscellaneous tariff bills) | TAR | 6 |
| Alcohol and Drug Abuse | ALC | 5 |
| Consumer Issues/Safety/Products | CSP | 5 |
Bills named in its filings
Bill numbers found in the filers' descriptions, most often named first.
| Bill | Congress | Times named |
|---|---|---|
| H.R. 5376 | 117th | 22 |
| H.R. 1 | 119th | 10 |
| H.R. 3 | 116th | 9 |
| S. 723 | 118th | 8 |
| H.R. 1458 | 118th | 8 |
| H.R. 1319 | 117th | 8 |
| H.R. 7051 | 117th | 8 |
| H.R. 1520 | 116th | 8 |
| H.R. 1503 | 116th | 8 |
| S. 2327 | 117th | 7 |
| S. 1895 | 116th | 7 |
| S. 1416 | 116th | 7 |
| H.R. 4378 | 116th | 6 |
| S. 1871 | 113th | 6 |
| H.R. 3717 | 113th | 6 |
| H.R. 308 | 118th | 5 |
| H.R. 5801 | 117th | 5 |
| S. 3427 | 117th | 5 |
| H.R. 6000 | 117th | 5 |
| H.R. 1865 | 116th | 5 |
| S. 3129 | 116th | 5 |
| S. 3013 | 116th | 5 |
| H.R. 3055 | 116th | 5 |
| H.R. 4302 | 113th | 5 |
| S. 2157 | 113th | 5 |
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.